Company profile for IMAC Holdings

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

IMAC Holdings was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life science advancements with traditional medical care for movement restricting diseases and conditions. IMAC owns or manages 16 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has par...
IMAC Holdings was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life science advancements with traditional medical care for movement restricting diseases and conditions. IMAC owns or manages 16 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes, opening six Ozzie Smith IMAC Regeneration Centers, two David Price IMAC Regeneration Centers

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2725 James Sanders Blvd. Paducah, KY 42001
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/09/10/3148163/0/en/Ignite-Proteomics-Announces-Collaboration-with-Inova-Health-on-a-Biomarker-Study-for-Late-Stage-Cancers.html

GLOBENEWSWIRE
10 Sep 2025

https://www.globenewswire.com/news-release/2025/08/07/3129696/0/en/IMAC-Holdings-Announces-Research-Collaboration-with-Vanderbilt-University-Medical-Center-to-Advance-Immuno-Oncology-Biomarker-Discovery.html

GLOBENEWSWIRE
07 Aug 2025

https://www.globenewswire.com/news-release/2025/02/24/3031122/0/en/Ignite-Proteomics-to-Present-Data-on-MHC-II-as-a-Predictor-of-Pembrolizumab-Response-at-NCCN-Annual-Conference.html

GLOBENEWSWIRE
24 Feb 2025

https://www.globenewswire.com/news-release/2025/02/19/3028862/0/en/Ignite-Proteomics-Completes-Acquisition-of-PLA-Code-0249U-for-Its-Advanced-Proteomic-Breast-Cancer-Assay.html

GLOBENEWSWIRE
19 Feb 2025

https://www.globenewswire.com/news-release/2025/02/10/3023512/0/en/Ignite-Proteomics-Announces-Publication-of-Study-Demonstrating-Superiority-of-Protein-Activation-Analysis-in-Predicting-Breast-Cancer-Therapy-Response.html

GLOBENEWSWIRE
10 Feb 2025

https://www.globenewswire.com/news-release/2025/01/27/3015982/0/en/IMAC-Holdings-Introduces-Ignite-Proteomics-A-New-Standard-for-Matching-Patients-with-the-Right-Cancer-Therapies.html

GLOBENEWSWIRE
27 Jan 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty